Causes of death in HIV-infected patients from the Cologne-Bonn cohort

Ehren, K.; Hertenstein, C.; Kümmerle, T.; Vehreschild, J.; Fischer, J.; Gillor, D.; Wyen, C.; Lehmann, C.; Cornely, O.; Jung, N.; Gravemann, S.; Platten, M.; Wasmuth, J.; Rockstroh, J.; Boesecke, C.; Schwarze-Zander, C.; Fätkenheuer, G.
February 2014
Infection;Feb2014, Vol. 42 Issue 1, p135
Academic Journal
Purpose: Causes of death in human immunodeficiency virus (HIV)-infected subjects have changed in countries with high resources over the last several years. Acquired immunodeficiency syndrome (AIDS)-related diseases have become less prevalent, whereas deaths due to non-AIDS causes are increasing. The aim of the present study was to analyse causes of death in the Cologne-Bonn cohort. Methods: Causes of death from the Cologne-Bonn cohort between 2004 and 2010 were systematically recorded using the CoDe algorithm (The Coding Causes of Death in HIV Project). Results: In 3,165 patients followed from 2004 to 2010, 182 deaths occurred (5.7 %, 153 males, 29 females). The median age at the time of death was 47 years (range 24-85 years). The most frequent causes of death were AIDS-defining events ( n = 60, 33 %), with non-Hodgkin lymphoma (NHL) ( n = 29, 16 %) and infections ( n = 20, 11 %) being the leading entities in this category. Non-AIDS malignancies accounted for 16 % ( n = 29), non-HIV-related infections for 10 % ( n = 18), cardiovascular diseases for 7 % ( n = 14), suicide or accident for 4 % ( n = 7) and liver diseases for 3 % ( n = 5) of deaths (unknown n = 47, 26 %). Although the majority of patients (92.5 %) was on antiretroviral therapy (ART), only 50 % were virologically suppressed (HIV-RNA <50 copies/mL) and 44 % had a decreased CD4+ count (<200/μL) at their last visit before death. Conclusion: One-third of the causes of death in our cohort between 2004 and 2010 was AIDS-related. Since most of these deaths occur with severe immune suppression, they can possibly be prevented by the early diagnosis and treatment of HIV infection. Care providers must be aware of an increased risk for a broad range of diseases in HIV-infected patients and should apply appropriate preventive measures.


Related Articles

  • Clinical course and quality of care in ART-naïve patients newly presenting in a HIV outpatient clinic. Platten, M.; Linnemann, R.; Kümmerle, T.; Jung, N.; Wyen, C.; Ehren, K.; Gravemann, S.; Gillor, D.; Cornely, O.; Fischer, J.; Lehmann, C.; Rockstroh, J.; Fätkenheuer, G.; Vehreschild, J. // Infection;Oct2014, Vol. 42 Issue 5, p849 

    Objectives: Little data exist about the quality of care for HIV-infected subjects in Germany. We investigated the clinical course of HIV-infected subjects newly presenting in our HIV outpatient clinic. Methods: Antiretroviral therapy (ART)-naïve HIV-infected subjects presenting between 2007...

  • Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy. Winston, Alan; Duncombe, Chris; Li, Patrick; Gill, John; Kerr, Stephen; Puls, Rebekah; Taylor-Robinson, Simon; Emery, Sean; Cooper, David // Neuroradiology;Dec2012, Vol. 54 Issue 12, p1331 

    Introduction: Cerebral function impairment remains problematic in subjects with chronic human immunodeficiency virus (HIV) infection despite effective combination antiretroviral therapy (cART). Using cerebral proton magnetic resonance spectroscopy (H MRS), we aimed to determine if abnormalities...

  • The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models. Ford, Deborah; Robins, James M.; Petersen, Maya L.; Gibb, Diana M.; Gilks, Charles F.; Mugyenyi, Peter; Grosskurth, Heiner; Hakim, James; Katabira, Elly; Babiker, Abdel G.; Walker, A. Sarah // American Journal of Epidemiology;10/1/2015, Vol. 182 Issue 7, p633 

    In Africa, antiretroviral therapy (ART) is delivered with limited laboratory monitoring, often none. In 2003-2004, investigators in the Development of Antiretroviral Therapy in Africa (DART) Trial randomized persons initiating ART in Uganda and Zimbabwe to either laboratory and clinical...

  • Retention of antiretroviral naïve patients registered in HIV care in a program clinic in Pune, India. Ghate, Manisha V.; Zirpe, Sunil S.; Gurav, Nilam P.; Rewari, Bharat B.; Gangakhedkar, Raman R.; Paranjape, Ramesh S. // Indian Journal of Sexually Transmitted Diseases;Jul-Dec2014, Vol. 35 Issue 2, p124 

    Background: Retention in HIV care ensures delivery of services like secondary prevention, timely initiation of treatment, support, and care on a regular basis. The data on retention in pre antiretroviral therapy (ART) care in India is scanty. Materials and Methods: Antiretroviral naïve...

  • NUTRITIONAL STATUS OF PATIENTS WITH HIV/AIDS. Ferreira, Rosângela dos Santos; Ivo, Maria Lúcia; Uehara, Silvia Naomi de Oliveira; Pontes, Elenir Rose Jardim Cury; Pelizaro, Bruno Ivo; Ferreira Júnior, Marcos Antonio // Journal of Nursing UFPE / Revista de Enfermagem UFPE;Jun2012, Vol. 6 Issue 6, p1321 

    Objective: to characterize the nutritional status of patients with HIV/Aids, at the beginning and end of a twelve-month nutritional follow-up. Method: this is a prospective descriptive cohort study carried out at Day-Hospital Prof. Esterina Corsini, of Universidade Federal de Mato Grosso do Sul,...

  • Pattern of mucocutaneous manifestations in human immunodeficiency virus-positive patients in North India. Kore, Sachin D.; Kanwar, Amrinder J.; Vinay, Keshavamurthy; Wanchu, Ajay // Indian Journal of Sexually Transmitted Diseases;Jan-Jun2013, Vol. 34 Issue 1, p19 

    Background: Mucocutaneous diseases are among the first-recognized clinical manifestations of acquired immune deficiency syndrome. They function as visual markers in assessing the progression of human immunodeficiency virus (HIV) infection. Given the relative ease of examination of skin, its...

  • Using Community Health Workers to Improve Clinical Outcomes Among People Living with HIV: A Randomized Controlled Trial. Kenya, Sonjia; Jones, Jamal; Arheart, Kristopher; Kobetz, Erin; Chida, Natasha; Baer, Shelly; Powell, Alexis; Symes, Stephen; Hunte, Tai; Monroe, Anne; Carrasquillo, Olveen // AIDS & Behavior;Nov2013, Vol. 17 Issue 9, p2927 

    AIDS-related mortality remains a leading cause of preventable death among African-Americans. We sought to determine if community health workers could improve clinical outcomes among vulnerable African-Americans living with HIV in Miami, Florida. We recruited 91 medically indigent persons with...

  • Patient Perspectives on Leaving, Disengaging, and Returning to HIV Care. Gill, Victoria C.; Krentz, Hartmut B. // AIDS Patient Care & STDs;Jul2015, Vol. 29 Issue 7, p400 

    Continuity of care is the cornerstone of all modern HIV disease management guidelines. Interruptions in care due to disengagement or moving between HIV care centers are common occurrences often contributing to poorer health. In order to understand why patients disengage from HIV care we first...

  • Disparities in Viral Load and CD4 Count Trends Among HIV-Infected Adults in South Carolina. Chakraborty, Hrishikesh; Iyer, Medha; Duffus, Wayne A.; Samantapudi, Ashok Varma; Albrecht, Helmut; Weissman, Sharon // AIDS Patient Care & STDs;Jan2015, Vol. 29 Issue 1, p26 

    On a population level, trends in viral load (VL) and CD4 cell counts can provide a marker of infectivity and an indirect measure of retention in care. Thus, observing the trend of CD4/VL over time can provide useful information on disparities in populations across the HIV care continuum when...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics